trimethyloxamine has been researched along with Acute Coronary Syndrome in 9 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
Acute Coronary Syndrome: An episode of MYOCARDIAL ISCHEMIA that generally lasts longer than a transient anginal episode that ultimately may lead to MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Trimethyllysine (TML) serves as a nutrient precursor of the gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) and is associated with incident cardiovascular (CV) events in stable subjects." | 5.51 | Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes. ( Chung, YM; Gu, X; Hazen, BJ; Hazen, SL; Hurd, AG; Levison, BS; Li, L; Li, XS; Lüscher, TF; Mach, F; Matter, CM; Nanchen, D; Nissen, SE; Obeid, S; Pratt, A; Räber, L; Tang, WHW; Wang, Z; Wu, Y, 2019) |
| "ACS and incident post-STEMI MACE may be associated with the gut bacteria choline metabolite TMAO." | 1.56 | Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events. ( Dou, J; Gao, J; Liu, Y; Ma, J; Ren, M; Wang, J; Wang, JX; Yan, KT; Zhang, X, 2020) |
| "Trimethyllysine (TML) serves as a nutrient precursor of the gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) and is associated with incident cardiovascular (CV) events in stable subjects." | 1.51 | Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes. ( Chung, YM; Gu, X; Hazen, BJ; Hazen, SL; Hurd, AG; Levison, BS; Li, L; Li, XS; Lüscher, TF; Mach, F; Matter, CM; Nanchen, D; Nissen, SE; Obeid, S; Pratt, A; Räber, L; Tang, WHW; Wang, Z; Wu, Y, 2019) |
| "Betaine is a major osmolyte, also important in methyl group metabolism." | 1.40 | Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study. ( Atkinson, W; Bellamy, D; Chambers, ST; Elmslie, JL; Frampton, CM; George, PM; Ho, M; Lever, M; McEntyre, CJ; Molyneux, SL; Richards, AM; Slow, S; Troughton, RW; Young, JM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Konieczny, RA | 1 |
| Żurawska-Płaksej, E | 1 |
| Kaaz, K | 1 |
| Czapor-Irzabek, H | 1 |
| Bombała, W | 1 |
| Mysiak, A | 1 |
| Kuliczkowski, W | 1 |
| Gao, J | 1 |
| Yan, KT | 1 |
| Wang, JX | 1 |
| Dou, J | 1 |
| Wang, J | 1 |
| Ren, M | 1 |
| Ma, J | 1 |
| Zhang, X | 1 |
| Liu, Y | 1 |
| Tascanov, MB | 1 |
| Tanriverdi, Z | 1 |
| Gungoren, F | 1 |
| Besli, F | 1 |
| Erkus, ME | 1 |
| Koyuncu, I | 1 |
| Gonel, A | 1 |
| Genc Tapar, G | 1 |
| Li, XS | 2 |
| Obeid, S | 2 |
| Wang, Z | 2 |
| Hazen, BJ | 1 |
| Li, L | 2 |
| Wu, Y | 2 |
| Hurd, AG | 1 |
| Gu, X | 1 |
| Pratt, A | 1 |
| Levison, BS | 1 |
| Chung, YM | 2 |
| Nissen, SE | 1 |
| Tang, WHW | 1 |
| Mach, F | 2 |
| Räber, L | 2 |
| Nanchen, D | 2 |
| Matter, CM | 2 |
| Lüscher, TF | 2 |
| Hazen, SL | 2 |
| Schiattarella, GG | 1 |
| Trimarco, B | 1 |
| Lever, M | 1 |
| George, PM | 1 |
| Slow, S | 1 |
| Bellamy, D | 1 |
| Young, JM | 1 |
| Ho, M | 1 |
| McEntyre, CJ | 1 |
| Elmslie, JL | 1 |
| Atkinson, W | 1 |
| Molyneux, SL | 1 |
| Troughton, RW | 1 |
| Frampton, CM | 1 |
| Richards, AM | 1 |
| Chambers, ST | 1 |
| Klingenberg, R | 1 |
| Gencer, B | 1 |
| Windecker, S | 1 |
| Rodondi, N | 1 |
| Muller, O | 1 |
| Miranda, MX | 1 |
| Alamri, HS | 1 |
| Gogonea, V | 1 |
| Tang, WH | 1 |
| Fernández-Ruiz, I | 1 |
| Trøseid, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effects of a Whole Food Based Nutritional Formulation on Trimethylamine N-oxide and Cardiometabolic Endpoints in Healthy Adults.[NCT05795946] | 45 participants (Anticipated) | Interventional | 2023-04-15 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for trimethyloxamine and Acute Coronary Syndrome
| Article | Year |
|---|---|
Citrulline and long-term mortality in patients with cardiovascular disease.
Topics: Acute Coronary Syndrome; Biomarkers; Cardiovascular Diseases; Citrulline; Female; Humans; Male; Midd | 2022 |
Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events.
Topics: Acute Coronary Syndrome; Adult; Biomarkers; Female; Gastrointestinal Microbiome; Humans; Male; Methy | 2020 |
Comparisons of microbiota-generated metabolites in patients with young and elderly acute coronary syndrome.
Topics: Acute Coronary Syndrome; Adult; Age Factors; Aged; Biomarkers; Choline; Female; Humans; Male; Methyl | 2020 |
Trimethyllysine, a trimethylamine N-oxide precursor, provides near- and long-term prognostic value in patients presenting with acute coronary syndromes.
Topics: Acute Coronary Syndrome; Aged; Female; Humans; Lysine; Male; Methylamines; Middle Aged; Prognosis; P | 2019 |
Microbial metabolites as predictive biomarkers: a paradigm shift for cardiovascular risk stratification.
Topics: Acute Coronary Syndrome; Biomarkers; Cardiovascular Diseases; Humans; Lysine; Methylamines; Prognosi | 2019 |
Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study.
Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Betaine; Biomarkers; Cardiovascular Diseases; Case | 2014 |
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors.
Topics: Acute Coronary Syndrome; Biomarkers; Cardiotonic Agents; Case-Control Studies; Female; Gastrointesti | 2017 |
Acute coronary syndromes: Microbial-dependent TMAO as a prognostic marker in ACS.
Topics: Acute Coronary Syndrome; Gastrointestinal Microbiome; Humans; Methylamines; Prognosis; Risk Factors | 2017 |
Gut microbiota and acute coronary syndromes: ready for use in the emergency room?
Topics: Acute Coronary Syndrome; Emergency Service, Hospital; Gastrointestinal Microbiome; Humans; Methylami | 2017 |